A. A. Barrera Rodriguez

A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy

P. Emery, J. Vencovský, A. Sylwestrzak, 2015, Annals of the rheumatic diseases.

52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis

P. Emery, J. Vencovský, A. Sylwestrzak, 2017, Rheumatology.

FRI0128 A Phase III Randomised, Double-Blind Clinical Study Comparing SB4, An Etanercept Biosimilar, With Etanercept Reference Product (Enbrel®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (24-Week Results)

P. Emery, J. Vencovský, A. Sylwestrzak, 2015 .